Document Type


Journal Title

PLoS Biology

Publication Date





SARS-CoV-2 infections are characterized by viral proliferation and clearance phases and can be followed by low-level persistent viral RNA shedding. The dynamics of viral RNA concentration, particularly in the early stages of infection, can inform clinical measures and interventions such as test-based screening. We used prospective longitudinal quantitative reverse transcription PCR testing to measure the viral RNA trajectories for 68 individuals during the resumption of the 2019-2020 National Basketball Association season. For 46 individuals with acute infections, we inferred the peak viral concentration and the duration of the viral proliferation and clearance phases. According to our mathematical model, we found that viral RNA concentrations peaked an average of 3.3 days (95% credible interval [CI] 2.5, 4.2) after first possible detectability at a cycle threshold value of 22.3 (95% CI 20.5, 23.9). The viral clearance phase lasted longer for symptomatic individuals (10.9 days [95% CI 7.9, 14.4]) than for asymptomatic individuals (7.8 days [95% CI 6.1, 9.7]). A second test within 2 days after an initial positive PCR test substantially improves certainty about a patient's infection stage. The effective sensitivity of a test intended to identify infectious individuals declines substantially with test turnaround time. These findings indicate that SARS-CoV-2 viral concentrations peak rapidly regardless of symptoms. Sequential tests can help reveal a patient's progress through infection stages. Frequent, rapid-turnaround testing is needed to effectively screen individuals before they become infectious.



Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_1.pdf (79 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_2.pdf (565 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_3.pdf (557 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_4.pdf (536 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_5.pdf (519 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_6.pdf (81 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_7.pdf (269 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_8.pdf (191 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_9.pdf (372 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_10.pdf (362 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_11.pdf (340 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_12.pdf (601 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_13.pdf (823 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_14.pdf (125 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_15.pdf (109 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_16.pdf (83 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_17.pdf (85 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_18.pdf (138 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_19.pdf (140 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_20.pdf (105 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_21.pdf (60 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_22.pdf (60 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_23.pdf (60 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_24.pdf (62 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_25.pdf (62 kB)
Viral_dynamics_of_acute_SARS-CoV-2_infection_supplement_26.pdf (315 kB)

Included in

Epidemiology Commons